在北印度1型糖尿病儿童中使用补充和替代医学的实践:一项探索性研究
Priyanka Walia1, Latika Rohilla2, Devi Dayal2
1Endocrinology and Diabetes Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Diabetology international
|March 25, 2024
概括
北印度的1型糖尿病 (T1DM) 儿童经常使用补充和替代药物 (CAM),通常会对血糖控制产生负面影响. 这种做法需要在糖尿病教育中提高认识,以防止不良健康后果.
科学领域:
- 儿科 儿科 儿科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 1型糖尿病 (T1DM) 的管理需要谨慎的胰岛素治疗.
- 与胰岛素同时使用补充和替代药物 (CAM) 可能会导致小儿T1DM患者的不良反应.
- 了解CAM使用模式对于优化T1DM护理至关重要.
研究的目的:
- 探索补充和替代医学 (CAM) 在1型糖尿病 (T1DM) 的儿童中使用的流行率和模式.
- 调查父母在T1DM管理中使用CAM的动机.
- 评估CAM对儿科T1DM血糖控制的感知影响.
主要方法:
- 采用了一个探索性研究设计.
- 通过使用结构化问卷,从参加第三级糖尿病诊所的T1DM儿童的父母那里收集数据.
- 183名家长 (91.5%的响应率) 完成了调查.
主要成果:
- 36.6%的家长表示,他们为患有T1DM的孩子使用CAM.
- 使用CAM的常见原因包括感知到的治疗性质 (62.7%) 和改善血糖控制 (28.3%).
- 阿尤尔韦达和顺势疗法制剂是最常用的CAM. 40.2%的CAM使用者报告说,血糖控制较差.
结论:
- 补充和替代药物通常被北印度的T1DM儿童使用.
- 使用CAM,特别是草药,与对血糖控制的有害影响有关.
- 医疗保健提供者应将关于CAM的讨论纳入糖尿病教育中,以防止因低于最佳剂量的胰岛素而导致的紧急情况.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196
Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530


